APRETUDE
APRETUDE
Approved
DIN Number
02547473
Drug Class
Human
Market Date
Jun 19, 2024
Company
HC
viiv healthcare ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02547473
AIG Number0162114002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AJ04 CABOTEGRAVIR
Product Specifications
Dosage FormSuspension (Extended-Release)
Route of AdministrationIntramuscular
AHFS Classification08:18.08.12
Health Canada Classification
ACTIVE INGREDIENTS (1)
CABOTEGRAVIRActive
Strength: 200 MG / ML
Monograph: CABOTEGRAVIR